{"nctId":"NCT02085135","briefTitle":"A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)","startDateStruct":{"date":"2014-02"},"conditions":["Major Depressive Disorder"],"count":66,"armGroups":[{"label":"Titration Schedule 1","type":"EXPERIMENTAL","interventionNames":["Drug: ALKS 5461"]},{"label":"Titration Schedule 2","type":"EXPERIMENTAL","interventionNames":["Drug: ALKS 5461"]}],"interventions":[{"name":"ALKS 5461","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Body mass index of 18-40 kg/m2\n* Have a diagnosis of MDD\n* Have a current major depressive episode (MDE) lasting 8 weeks to 24 months\n* Have been treated with an adequate dose of an approved antidepressant during the current MDE for at least 8 weeks\n* Have an inadequate response to current antidepressant treatment\n* Agree to use an approved method of birth control for the duration of the study\n* Additional criteria may apply\n\nExclusion Criteria:\n\n* Currently pregnant or breastfeeding\n* History of or current infection with Hepatitis B Virus, Hepatitis C Virus or Human Immunodeficiency Virus (HIV)\n* Have experienced hallucinations, delusions, or any psychotic symptoms in the current MDE\n* Have used opioid agonists (eg, codeine, oxycodone, tramadol, or morphine) or opioid antagonists (eg, naloxone, naltrexone) within 14 days\n* Have received electroconvulsive therapy treatment within the last 5 years\n* Have attempted suicide within the past 2 years\n* Have a history of intolerance, allergy, or hypersensitivity to buprenorphine or opioid antagonists (eg, naltrexone, naloxone)\n* Have had a significant blood loss or blood donation with 60 days of screening\n* Additional criteria may apply","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Subjects With Adverse Events (AEs)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"28","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":34},"commonTop":["Constipation","Nausea","Dry Mouth","Headache","Vomiting"]}}}